nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP1A2—Dacarbazine—pancreatic cancer	0.0785	0.0985	CbGbCtD
Desloratadine—CYP2C19—Tamoxifen—pancreatic cancer	0.0677	0.085	CbGbCtD
Desloratadine—CYP1A2—Tamoxifen—pancreatic cancer	0.0625	0.0784	CbGbCtD
Desloratadine—CYP2C9—Tamoxifen—pancreatic cancer	0.0563	0.0706	CbGbCtD
Desloratadine—ABCB1—Tamoxifen—pancreatic cancer	0.0546	0.0686	CbGbCtD
Desloratadine—CYP1A2—Erlotinib—pancreatic cancer	0.0531	0.0667	CbGbCtD
Desloratadine—CYP2D6—Tamoxifen—pancreatic cancer	0.0515	0.0646	CbGbCtD
Desloratadine—ABCB1—Gemcitabine—pancreatic cancer	0.0471	0.0591	CbGbCtD
Desloratadine—ABCB1—Erlotinib—pancreatic cancer	0.0465	0.0583	CbGbCtD
Desloratadine—CYP1A2—Fluorouracil—pancreatic cancer	0.046	0.0578	CbGbCtD
Desloratadine—CYP2D6—Erlotinib—pancreatic cancer	0.0438	0.0549	CbGbCtD
Desloratadine—ABCB1—Irinotecan—pancreatic cancer	0.042	0.0526	CbGbCtD
Desloratadine—CYP2C9—Fluorouracil—pancreatic cancer	0.0415	0.0521	CbGbCtD
Desloratadine—ABCB1—Docetaxel—pancreatic cancer	0.0307	0.0386	CbGbCtD
Desloratadine—ABCB1—Sunitinib—pancreatic cancer	0.0306	0.0384	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—pancreatic cancer	0.0229	0.0288	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—pancreatic cancer	0.0216	0.0271	CbGbCtD
Desloratadine—Fatigue—Sunitinib—pancreatic cancer	0.000596	0.00294	CcSEcCtD
Desloratadine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000595	0.00293	CcSEcCtD
Desloratadine—Cough—Gemcitabine—pancreatic cancer	0.000593	0.00292	CcSEcCtD
Desloratadine—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000584	0.00288	CcSEcCtD
Desloratadine—Epistaxis—Docetaxel—pancreatic cancer	0.000582	0.00287	CcSEcCtD
Desloratadine—Asthenia—Tamoxifen—pancreatic cancer	0.000579	0.00285	CcSEcCtD
Desloratadine—Convulsion—Fluorouracil—pancreatic cancer	0.000579	0.00285	CcSEcCtD
Desloratadine—Myalgia—Gemcitabine—pancreatic cancer	0.000579	0.00285	CcSEcCtD
Desloratadine—Increased appetite—Epirubicin—pancreatic cancer	0.000575	0.00283	CcSEcCtD
Desloratadine—Asthenia—Erlotinib—pancreatic cancer	0.000573	0.00282	CcSEcCtD
Desloratadine—Pruritus—Tamoxifen—pancreatic cancer	0.000571	0.00281	CcSEcCtD
Desloratadine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00057	0.00281	CcSEcCtD
Desloratadine—Oedema—Irinotecan—pancreatic cancer	0.00057	0.00281	CcSEcCtD
Desloratadine—Myalgia—Fluorouracil—pancreatic cancer	0.000569	0.0028	CcSEcCtD
Desloratadine—Infection—Irinotecan—pancreatic cancer	0.000566	0.00279	CcSEcCtD
Desloratadine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000565	0.00279	CcSEcCtD
Desloratadine—Pruritus—Erlotinib—pancreatic cancer	0.000565	0.00278	CcSEcCtD
Desloratadine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000559	0.00275	CcSEcCtD
Desloratadine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000555	0.00273	CcSEcCtD
Desloratadine—Oedema—Gemcitabine—pancreatic cancer	0.000555	0.00273	CcSEcCtD
Desloratadine—Hepatitis—Docetaxel—pancreatic cancer	0.000554	0.00273	CcSEcCtD
Desloratadine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000552	0.00272	CcSEcCtD
Desloratadine—Infection—Gemcitabine—pancreatic cancer	0.000551	0.00272	CcSEcCtD
Desloratadine—Pharyngitis—Docetaxel—pancreatic cancer	0.00055	0.00271	CcSEcCtD
Desloratadine—Abdominal pain—Sunitinib—pancreatic cancer	0.000547	0.00269	CcSEcCtD
Desloratadine—Body temperature increased—Sunitinib—pancreatic cancer	0.000547	0.00269	CcSEcCtD
Desloratadine—Diarrhoea—Erlotinib—pancreatic cancer	0.000546	0.00269	CcSEcCtD
Desloratadine—Oedema—Fluorouracil—pancreatic cancer	0.000545	0.00269	CcSEcCtD
Desloratadine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000545	0.00269	CcSEcCtD
Desloratadine—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000545	0.00268	CcSEcCtD
Desloratadine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000544	0.00268	CcSEcCtD
Desloratadine—Anorexia—Irinotecan—pancreatic cancer	0.000543	0.00267	CcSEcCtD
Desloratadine—Infection—Fluorouracil—pancreatic cancer	0.000542	0.00267	CcSEcCtD
Desloratadine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000535	0.00264	CcSEcCtD
Desloratadine—Dizziness—Tamoxifen—pancreatic cancer	0.000534	0.00263	CcSEcCtD
Desloratadine—Tachycardia—Fluorouracil—pancreatic cancer	0.000532	0.00262	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—pancreatic cancer	0.000532	0.00262	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—pancreatic cancer	0.000532	0.00262	CcSEcCtD
Desloratadine—Anorexia—Gemcitabine—pancreatic cancer	0.000529	0.00261	CcSEcCtD
Desloratadine—Dizziness—Erlotinib—pancreatic cancer	0.000528	0.0026	CcSEcCtD
Desloratadine—Anorexia—Fluorouracil—pancreatic cancer	0.00052	0.00256	CcSEcCtD
Desloratadine—Insomnia—Irinotecan—pancreatic cancer	0.000515	0.00254	CcSEcCtD
Desloratadine—Cardiac disorder—Docetaxel—pancreatic cancer	0.000514	0.00253	CcSEcCtD
Desloratadine—Vomiting—Tamoxifen—pancreatic cancer	0.000513	0.00253	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—pancreatic cancer	0.000512	0.00252	CcSEcCtD
Desloratadine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000509	0.00251	CcSEcCtD
Desloratadine—Rash—Tamoxifen—pancreatic cancer	0.000509	0.00251	CcSEcCtD
Desloratadine—Dermatitis—Tamoxifen—pancreatic cancer	0.000509	0.00251	CcSEcCtD
Desloratadine—Vomiting—Erlotinib—pancreatic cancer	0.000508	0.0025	CcSEcCtD
Desloratadine—Dyspnoea—Irinotecan—pancreatic cancer	0.000508	0.0025	CcSEcCtD
Desloratadine—Somnolence—Irinotecan—pancreatic cancer	0.000506	0.00249	CcSEcCtD
Desloratadine—Headache—Tamoxifen—pancreatic cancer	0.000506	0.00249	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000505	0.00249	CcSEcCtD
Desloratadine—Rash—Erlotinib—pancreatic cancer	0.000504	0.00248	CcSEcCtD
Desloratadine—Dermatitis—Erlotinib—pancreatic cancer	0.000503	0.00248	CcSEcCtD
Desloratadine—Insomnia—Gemcitabine—pancreatic cancer	0.000502	0.00247	CcSEcCtD
Desloratadine—Dyspepsia—Irinotecan—pancreatic cancer	0.000501	0.00247	CcSEcCtD
Desloratadine—Headache—Erlotinib—pancreatic cancer	0.0005	0.00246	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000497	0.00245	CcSEcCtD
Desloratadine—Asthenia—Sunitinib—pancreatic cancer	0.000496	0.00244	CcSEcCtD
Desloratadine—Decreased appetite—Irinotecan—pancreatic cancer	0.000495	0.00244	CcSEcCtD
Desloratadine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000495	0.00244	CcSEcCtD
Desloratadine—Insomnia—Fluorouracil—pancreatic cancer	0.000493	0.00243	CcSEcCtD
Desloratadine—Somnolence—Gemcitabine—pancreatic cancer	0.000493	0.00243	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—pancreatic cancer	0.000492	0.00242	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000492	0.00242	CcSEcCtD
Desloratadine—Fatigue—Irinotecan—pancreatic cancer	0.000491	0.00242	CcSEcCtD
Desloratadine—Pruritus—Sunitinib—pancreatic cancer	0.000489	0.00241	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—pancreatic cancer	0.000488	0.00241	CcSEcCtD
Desloratadine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000486	0.0024	CcSEcCtD
Desloratadine—Mental disorder—Docetaxel—pancreatic cancer	0.000485	0.00239	CcSEcCtD
Desloratadine—Somnolence—Fluorouracil—pancreatic cancer	0.000485	0.00239	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000483	0.00238	CcSEcCtD
Desloratadine—Erythema—Docetaxel—pancreatic cancer	0.000482	0.00238	CcSEcCtD
Desloratadine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000482	0.00238	CcSEcCtD
Desloratadine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00048	0.00237	CcSEcCtD
Desloratadine—Nausea—Tamoxifen—pancreatic cancer	0.000479	0.00236	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000479	0.00236	CcSEcCtD
Desloratadine—Fatigue—Gemcitabine—pancreatic cancer	0.000478	0.00236	CcSEcCtD
Desloratadine—Nausea—Erlotinib—pancreatic cancer	0.000474	0.00234	CcSEcCtD
Desloratadine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000474	0.00234	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—pancreatic cancer	0.000474	0.00233	CcSEcCtD
Desloratadine—Diarrhoea—Sunitinib—pancreatic cancer	0.000473	0.00233	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000471	0.00232	CcSEcCtD
Desloratadine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000466	0.00229	CcSEcCtD
Desloratadine—Dizziness—Sunitinib—pancreatic cancer	0.000457	0.00225	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—pancreatic cancer	0.000452	0.00223	CcSEcCtD
Desloratadine—Abdominal pain—Irinotecan—pancreatic cancer	0.00045	0.00222	CcSEcCtD
Desloratadine—Body temperature increased—Irinotecan—pancreatic cancer	0.00045	0.00222	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—pancreatic cancer	0.000449	0.00221	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000447	0.0022	CcSEcCtD
Desloratadine—Vomiting—Sunitinib—pancreatic cancer	0.00044	0.00217	CcSEcCtD
Desloratadine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000439	0.00216	CcSEcCtD
Desloratadine—Rash—Sunitinib—pancreatic cancer	0.000436	0.00215	CcSEcCtD
Desloratadine—Dermatitis—Sunitinib—pancreatic cancer	0.000436	0.00215	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000434	0.00214	CcSEcCtD
Desloratadine—Urticaria—Fluorouracil—pancreatic cancer	0.000433	0.00213	CcSEcCtD
Desloratadine—Headache—Sunitinib—pancreatic cancer	0.000433	0.00213	CcSEcCtD
Desloratadine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000431	0.00212	CcSEcCtD
Desloratadine—Palpitations—Docetaxel—pancreatic cancer	0.000426	0.0021	CcSEcCtD
Desloratadine—Cough—Docetaxel—pancreatic cancer	0.000421	0.00207	CcSEcCtD
Desloratadine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00042	0.00207	CcSEcCtD
Desloratadine—Convulsion—Docetaxel—pancreatic cancer	0.000418	0.00206	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—pancreatic cancer	0.000416	0.00205	CcSEcCtD
Desloratadine—Infestation—Epirubicin—pancreatic cancer	0.000416	0.00205	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—pancreatic cancer	0.000416	0.00205	CcSEcCtD
Desloratadine—Myalgia—Docetaxel—pancreatic cancer	0.000411	0.00202	CcSEcCtD
Desloratadine—Nausea—Sunitinib—pancreatic cancer	0.000411	0.00202	CcSEcCtD
Desloratadine—Asthenia—Irinotecan—pancreatic cancer	0.000409	0.00201	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000405	0.00199	CcSEcCtD
Desloratadine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000402	0.00198	CcSEcCtD
Desloratadine—Dry mouth—Docetaxel—pancreatic cancer	0.000402	0.00198	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000402	0.00198	CcSEcCtD
Desloratadine—Asthenia—Gemcitabine—pancreatic cancer	0.000398	0.00196	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000394	0.00194	CcSEcCtD
Desloratadine—Oedema—Docetaxel—pancreatic cancer	0.000394	0.00194	CcSEcCtD
Desloratadine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000394	0.00194	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—pancreatic cancer	0.000393	0.00193	CcSEcCtD
Desloratadine—Pruritus—Gemcitabine—pancreatic cancer	0.000392	0.00193	CcSEcCtD
Desloratadine—Infection—Docetaxel—pancreatic cancer	0.000391	0.00193	CcSEcCtD
Desloratadine—Diarrhoea—Irinotecan—pancreatic cancer	0.00039	0.00192	CcSEcCtD
Desloratadine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000386	0.0019	CcSEcCtD
Desloratadine—Pruritus—Fluorouracil—pancreatic cancer	0.000386	0.0019	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000385	0.0019	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—pancreatic cancer	0.000385	0.0019	CcSEcCtD
Desloratadine—Tachycardia—Docetaxel—pancreatic cancer	0.000384	0.00189	CcSEcCtD
Desloratadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00038	0.00187	CcSEcCtD
Desloratadine—Dizziness—Irinotecan—pancreatic cancer	0.000377	0.00186	CcSEcCtD
Desloratadine—Anorexia—Docetaxel—pancreatic cancer	0.000375	0.00185	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000374	0.00184	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—pancreatic cancer	0.000374	0.00184	CcSEcCtD
Desloratadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000373	0.00184	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—pancreatic cancer	0.000371	0.00183	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000367	0.00181	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000364	0.00179	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—pancreatic cancer	0.000363	0.00179	CcSEcCtD
Desloratadine—Vomiting—Irinotecan—pancreatic cancer	0.000362	0.00178	CcSEcCtD
Desloratadine—Dizziness—Fluorouracil—pancreatic cancer	0.000361	0.00178	CcSEcCtD
Desloratadine—Rash—Irinotecan—pancreatic cancer	0.000359	0.00177	CcSEcCtD
Desloratadine—Dermatitis—Irinotecan—pancreatic cancer	0.000359	0.00177	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000359	0.00177	CcSEcCtD
Desloratadine—Headache—Irinotecan—pancreatic cancer	0.000357	0.00176	CcSEcCtD
Desloratadine—Insomnia—Docetaxel—pancreatic cancer	0.000356	0.00175	CcSEcCtD
Desloratadine—Vomiting—Gemcitabine—pancreatic cancer	0.000353	0.00174	CcSEcCtD
Desloratadine—Dyspnoea—Docetaxel—pancreatic cancer	0.000351	0.00173	CcSEcCtD
Desloratadine—Somnolence—Docetaxel—pancreatic cancer	0.00035	0.00172	CcSEcCtD
Desloratadine—Rash—Gemcitabine—pancreatic cancer	0.00035	0.00172	CcSEcCtD
Desloratadine—Dermatitis—Gemcitabine—pancreatic cancer	0.000349	0.00172	CcSEcCtD
Desloratadine—Headache—Gemcitabine—pancreatic cancer	0.000348	0.00171	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000347	0.00171	CcSEcCtD
Desloratadine—Vomiting—Fluorouracil—pancreatic cancer	0.000347	0.00171	CcSEcCtD
Desloratadine—Dyspepsia—Docetaxel—pancreatic cancer	0.000347	0.00171	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—pancreatic cancer	0.000346	0.0017	CcSEcCtD
Desloratadine—Rash—Fluorouracil—pancreatic cancer	0.000344	0.00169	CcSEcCtD
Desloratadine—Dermatitis—Fluorouracil—pancreatic cancer	0.000344	0.00169	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000343	0.00169	CcSEcCtD
Desloratadine—Decreased appetite—Docetaxel—pancreatic cancer	0.000342	0.00169	CcSEcCtD
Desloratadine—Headache—Fluorouracil—pancreatic cancer	0.000342	0.00168	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00034	0.00167	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00034	0.00167	CcSEcCtD
Desloratadine—Fatigue—Docetaxel—pancreatic cancer	0.000339	0.00167	CcSEcCtD
Desloratadine—Nausea—Irinotecan—pancreatic cancer	0.000338	0.00167	CcSEcCtD
Desloratadine—Nausea—Gemcitabine—pancreatic cancer	0.00033	0.00162	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—pancreatic cancer	0.000327	0.00161	CcSEcCtD
Desloratadine—Erythema—Epirubicin—pancreatic cancer	0.000325	0.0016	CcSEcCtD
Desloratadine—Nausea—Fluorouracil—pancreatic cancer	0.000324	0.0016	CcSEcCtD
Desloratadine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000322	0.00159	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000321	0.00158	CcSEcCtD
Desloratadine—Abdominal pain—Docetaxel—pancreatic cancer	0.000311	0.00153	CcSEcCtD
Desloratadine—Body temperature increased—Docetaxel—pancreatic cancer	0.000311	0.00153	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—pancreatic cancer	0.000303	0.00149	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—pancreatic cancer	0.000301	0.00148	CcSEcCtD
Desloratadine—Agitation—Epirubicin—pancreatic cancer	0.000299	0.00147	CcSEcCtD
Desloratadine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00029	0.00143	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—pancreatic cancer	0.000288	0.00142	CcSEcCtD
Desloratadine—Cough—Epirubicin—pancreatic cancer	0.000284	0.0014	CcSEcCtD
Desloratadine—Asthenia—Docetaxel—pancreatic cancer	0.000282	0.00139	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—pancreatic cancer	0.000282	0.00139	CcSEcCtD
Desloratadine—Pruritus—Docetaxel—pancreatic cancer	0.000279	0.00137	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—pancreatic cancer	0.000277	0.00136	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—pancreatic cancer	0.000277	0.00136	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—pancreatic cancer	0.000271	0.00133	CcSEcCtD
Desloratadine—Diarrhoea—Docetaxel—pancreatic cancer	0.000269	0.00133	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—pancreatic cancer	0.000266	0.00131	CcSEcCtD
Desloratadine—Oedema—Epirubicin—pancreatic cancer	0.000266	0.00131	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000266	0.00131	CcSEcCtD
Desloratadine—Infection—Epirubicin—pancreatic cancer	0.000264	0.0013	CcSEcCtD
Desloratadine—Cough—Doxorubicin—pancreatic cancer	0.000263	0.00129	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—pancreatic cancer	0.000261	0.00128	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00026	0.00128	CcSEcCtD
Desloratadine—Dizziness—Docetaxel—pancreatic cancer	0.00026	0.00128	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—pancreatic cancer	0.000259	0.00128	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—pancreatic cancer	0.000256	0.00126	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—pancreatic cancer	0.000253	0.00125	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—pancreatic cancer	0.000251	0.00123	CcSEcCtD
Desloratadine—Vomiting—Docetaxel—pancreatic cancer	0.00025	0.00123	CcSEcCtD
Desloratadine—Rash—Docetaxel—pancreatic cancer	0.000248	0.00122	CcSEcCtD
Desloratadine—Dermatitis—Docetaxel—pancreatic cancer	0.000248	0.00122	CcSEcCtD
Desloratadine—Headache—Docetaxel—pancreatic cancer	0.000247	0.00121	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000246	0.00121	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—pancreatic cancer	0.000246	0.00121	CcSEcCtD
Desloratadine—Infection—Doxorubicin—pancreatic cancer	0.000244	0.0012	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000242	0.00119	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000241	0.00119	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—pancreatic cancer	0.00024	0.00118	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—pancreatic cancer	0.00024	0.00118	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—pancreatic cancer	0.000237	0.00117	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—pancreatic cancer	0.000236	0.00116	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—pancreatic cancer	0.000234	0.00115	CcSEcCtD
Desloratadine—Nausea—Docetaxel—pancreatic cancer	0.000234	0.00115	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—pancreatic cancer	0.000234	0.00115	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—pancreatic cancer	0.000231	0.00114	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000229	0.00113	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—pancreatic cancer	0.000229	0.00113	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000224	0.0011	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—pancreatic cancer	0.000222	0.00109	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000219	0.00108	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—pancreatic cancer	0.000218	0.00108	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000217	0.00107	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000216	0.00107	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000214	0.00105	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000212	0.00104	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—pancreatic cancer	0.000212	0.00104	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—pancreatic cancer	0.000211	0.00104	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—pancreatic cancer	0.00021	0.00103	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—pancreatic cancer	0.00021	0.00103	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000201	0.00099	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000196	0.000964	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—pancreatic cancer	0.000195	0.000962	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000194	0.000957	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000194	0.000957	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—pancreatic cancer	0.000191	0.000939	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—pancreatic cancer	0.000188	0.000926	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—pancreatic cancer	0.000182	0.000895	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000181	0.000892	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—pancreatic cancer	0.000176	0.000868	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—pancreatic cancer	0.000176	0.000865	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—pancreatic cancer	0.000174	0.000856	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—pancreatic cancer	0.000169	0.000832	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000168	0.000828	CcSEcCtD
Desloratadine—Rash—Epirubicin—pancreatic cancer	0.000167	0.000825	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—pancreatic cancer	0.000167	0.000824	CcSEcCtD
Desloratadine—Headache—Epirubicin—pancreatic cancer	0.000166	0.00082	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—pancreatic cancer	0.000162	0.0008	CcSEcCtD
Desloratadine—Nausea—Epirubicin—pancreatic cancer	0.000158	0.000777	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—pancreatic cancer	0.000156	0.00077	CcSEcCtD
Desloratadine—Rash—Doxorubicin—pancreatic cancer	0.000155	0.000763	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—pancreatic cancer	0.000155	0.000762	CcSEcCtD
Desloratadine—Headache—Doxorubicin—pancreatic cancer	0.000154	0.000758	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—pancreatic cancer	0.000146	0.000719	CcSEcCtD
